2010
DOI: 10.1186/1744-859x-9-16
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients

Abstract: BackgroundChronic obstructive pulmonary disease (COPD) is a major health problem, especially in adults over 40 years of age, and has a great social and economic impact. The psychological morbidity of COPD patients with regard to anxiety and depressive symptoms has been extensively studied in the past. However, few studies have investigated the prevalence of alexithymia in these patients, as well as its association with this comorbidity. Based on this fact, we studied the prevalence of alexithymia and its assoc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
23
2

Year Published

2011
2011
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(29 citation statements)
references
References 48 publications
3
23
2
Order By: Relevance
“…The fact that the predicted FEV 1 % and severity of COPD showed no correlation with anxiety or depression has been observed in other studies [6,68]. These observations are consistent with the hypothesis that the predicted FEV 1 % does not reflect all aspects of the disease [69].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…The fact that the predicted FEV 1 % and severity of COPD showed no correlation with anxiety or depression has been observed in other studies [6,68]. These observations are consistent with the hypothesis that the predicted FEV 1 % does not reflect all aspects of the disease [69].…”
Section: Discussionsupporting
confidence: 90%
“…Finally, the positive correlation between anxiety and depression is a common finding in both the general population [5,20] and in patients with COPD [1,6,68]. …”
Section: Discussionmentioning
confidence: 99%
“…Another factor that may have affected our results is the cut-off point of o19 in the BDI score that we selected for the distinction between patients with and without clinically important depressive symptoms. A previous validation study in the Greek general population [30] and a cross-sectional study in COPD patients have used different cut-off points [15]. However, we decided to use the cut-off from the original publication by BECK et al [13] which distinguishes patients with minimal or mild depressive symptoms from patients with moderate or severe depressive symptoms.…”
Section: Discussionmentioning
confidence: 99%
“…This cut-off point was previously used in a recent prospective study that enrolled COPD patients in a similar design to our study [14]. The Greek version of the BDI has been validated in the Greek population and has been evaluated recently in Greek COPD patients [15]. The official translation of BDI was provided by the Hellenic Institute of Psychology and Health (www.ipsy.gr).…”
Section: Study Parametersmentioning
confidence: 99%
“…Total scores range from 20 to 100. The TAS-20 is used worldwide for measuring alexithymia, and the empirically established cut off of ≥61 (Bagby & Taylor, 1997) was used in this study as this cut-off score has been used in a previous Greek study (Tselebis et al, 2010). A validated Greek version of the TAS-20 was used (Anagnostopoulou & Kioseoglou, 2002).…”
Section: Study Instrumentsmentioning
confidence: 99%